1. Introduction {#s0005}
===============

The anterior cruciate ligament (ACL) plays a crucial role in maintaining joint conformity and stability in the knee by restricting anterior displacement of the tibia relative to the femur ([@bib19], [@bib34]). However, injury to the ACL is commonplace, particularly amongst athletes and an increasingly more physically active population. If left untreated, ACL injuries can lead to meniscus damage and degenerative changes such as osteoarthritis ([@bib6], [@bib35]), causing further pain and impairment of the joint.

The most common surgical solution at present is to replace the damaged ACL with autograft tissue such as hamstring (semitendinosus and gracilis) tendon or patellar tendon grafts. Although hamstring tendon grafts have gained more recent popularity, owed in part to fewer donor-site complications ([@bib34]), bone--patellar tendon--bone grafts have been considered by some to be the "gold standard" of ACL replacement ([@bib41]) and can provide bone to bone apposition at fixation sites for more rapid integration. Furthermore, recent Norwegian and Danish registry studies indicate that patellar tendon autografts have a reduced risk of revision compared to hamstring tendon autografts ([@bib29], [@bib33]). All autografts result in some donor site morbidity and rehabilitation. Allografts provide an attractive option as they eliminate the need to harvest any autologous material whilst reducing the overall surgical time as well as avoiding donor site morbidity. However, these too have intrinsic disadvantages such as the possibility of adverse immunological reactions ([@bib32]). More fundamentally, both autologous and cryopreserved allogeneic graft choices suffer from the concern of preserving cell vitally. Once transplanted, it is unlikely that native cells remain vital and this can cause progressive degradation of the graft and its subsequent mechanical performance. This is because the rate of tissue degradation (as a result of necrosis) typically exceeds that of cellular in-growth and constructive remodelling ([@bib24], [@bib7]).

Tissue engineering offers a promising solution to replacement of the ruptured ACL. The ideal tissue engineered tendon scaffold should possess similar mechanical properties to native tendon, be biocompatible, composed of a biodegradable material and provide a supportive environment for cell ingrowth ([@bib31]). Synthetic or collagen Type I based scaffolds can be manufactured and used as platform to develop substitute tissues ([@bib19], [@bib30]). However, these usually fail to provide the multi-scale hierarchical matrix architectures present in the native ACL or autologous/allogeneic grafts. Biological scaffolds produced by decellularisation of native tissues have the advantage of providing this complex hierarchical matrix and, in doing so, reproduce closely the specific biomechanical and biological functions of the tissue in question. Hence, an acellular tendon/ligament graft may be ideally positioned to replace the native ACL without any of the current disadvantages of otherwise tissue engineered or autologous/allogeneic grafts.

Decellularisation treatments are multi-faceted, vary considerably between different processes and may involve many lengthy treatment steps. Some of these bio-processes may cause undesirable structural changes to the ECM of tissues and, by association, their mechanical properties ([@bib13], [@bib9]). Thus, in the case of an acellular graft for ACL replacement, it is of paramount importance to ensure that the properties of the tissue are not affected to the extent of reducing their biomechanical performance and longevity. Previously, we investigated acellular porcine super flexor tendon (pSFT) as a possible graft for ACL replacement and found that decellularisation caused the tissue to become more extensible in the toe region of loading ([@bib15]). This was deemed to be an effect of the treatment process altering the crimping pattern of collagen fibres. These changes are acceptable however, as they are unlikely to detract from the tissue providing sufficient stability and support when deployed in graft format.

In this study, we determined the material properties of acellular human patellar tendon (PT) grafts with a view to investigating the decellularisation process from a biomechanical perspective. It was hypothesised that the biomechanical changes found to occur in the pSFT as a result of the decellularisation process may also be evident in decellularised human PT grafts, and therefore it was necessary to determine the extent of these changes in this graft material.

2. Materials and methods {#s0010}
========================

2.1. Tissue sourcing and preparation {#s0015}
------------------------------------

Sixteen patella--tendon--tibia units were sourced from eight donors (six males, two females, mean 56.25 years old, range 45--69 years old), supplied by NHS Blood & Transplant Services (Speke, Liverpool, UK), with full ethical approval and consent for use in research. The central third of the patellar and tibial bone extremities were processed into rectangular blocks of approximately 10×10×30 mm and the central tendon element was trimmed to conform to the width of these bone sections. The bone extremities were preserved and processed in this manner in order to provide fixation points for future mechanical testing. In order to minimise left/right leg selection bias, four right and four left PT articles were chosen from random donors and allocated for decellularisation. The remaining articles served as an untreated, native control group. All specimens were then frozen at −40 °C during storage prior to further use.

2.2. Decellularisation {#s0020}
----------------------

Decellularisation was achieved using an adaption of a previously used protocol developed originally for the meniscus ([@bib36]). This consisted of subjecting specimens to three freeze/thaw cycles, two of which were followed by 10 min immersion in a sonicating bath, two 10 min cycles of centrifugation in phosphate buffered saline (PBS \[MP Biomedical LLP\]) at 1900*g* and then cycled through hypotonic buffer (50 mM Tris pH 8 \[Fisher Scientific\]) plus aprotinin (10 KIU ml^−1^ \[NHS Supplies, Leeds, UK\]) for 24 h, sodium dodecyl sulphate (0.1% (w/v) SDS \[Sigma\]) in hypotonic buffer plus aprotinin (10 KIU ml^−1^ \[NHS Supplies, Leeds, UK\]) for 24 h twice with agitation. Specimens were washed in PBS three times prior to two cycles of incubation in Benzonase (1 U ml^−1^ \[Merck\]) in 50 mM Tris--HCl, 10 mM MgCl~2~, pH 7.5 for 3 h at 37 °C with gentle agitation. Tissue was then washed in hypertonic buffer (1.5 M NaCl in 0.05 M Tris--HCl, pH 7.6) prior to washing in PBS and sterilisation in peracetic acid (0.1% (w/v) \[Sigma\]), before final PBS washes. All treatment steps were performed in 125 ml wash volumes in 150 ml sealed laboratory pots.

2.3. Biomechanical testing {#s0025}
--------------------------

The width and length of each patellar tendon were determined by calculating the average of three measurements with digital Vernier calipers. This method of measurement was deemed acceptable as it has been shown to produce results comparable to laser micrometre systems in similar tissues ([@bib40]). Thickness was measured in a similar fashion using a thickness gauge which applied a constant force of 0.65 N. To aid fixation, screws were placed transversely through both the patellar and tibial bone sections in the coronal plane, perpendicular to the tendons ([Fig. 1](#f0005){ref-type="fig"}a). These sections were then potted using poly-methyl methacrylate cement (WHW Plastics, Hull, UK) in bespoke fixtures. The fixtures had been manufactured in such a manner to allow for subsequent attachment to an Instron 3365 uniaxial testing system with 5 kN load cell (Instron, Bucks, UK) to load the specimens to failure ([Fig. 1](#f0005){ref-type="fig"}b). During the potting process, the soft tissues were isolated and protected from thermal injury by wrapping them in PBS soaked filter paper. This was removed immediately prior to mechanical testing.Fig. 1(a) Human PT specimens were processed to have 10×10×30 mm rectangular blocks of bone at each extremity, with a screw placed in each bone block to facilitate better fixation, (b) the bone blocks were then potted in PMMA cement in bespoke fixtures and mounted to an Instron where they were loaded until failure occurred.Fig. 1.

Testing consisted of 12 preconditioning cycles between 0 and 50 N at a strain rate of 0.01 s^−1^ to ensure the collagen fibres within the specimens were fully aligned to the axis of loading. This was then followed by an extension ramp to failure at the same strain rate. Such quasi-static loading conditions were chosen over more rapid physiological loading rates in order to limit the viscous contribution of the tissues to the mechanics. Hence, the tissues solid component (principally collagen Type I) was investigated alone with a view to decellularisation effects. Data was recorded at a frequency of 10 Hz. Engineering stress (*σ*) was calculated by dividing the force recorded by the load cell by the original cross-sectional area (width×thickness) of the ligament substance, whereas engineering strain (*ε*) was determined by dividing the crosshead displacement by the original length of the ligament substance.

Stress--strain data was then fitted to the following bi-linear model using non-linear least squares regression with a custom written Matlab script (Matlab (R2014a));$$\sigma = \mathit{E}_{0}.\epsilon{\quad\quad{for}}\quad\epsilon \leq \epsilon_{\ast}$$$$\sigma = E_{1}.\epsilon + c\quad{{for}\quad}\epsilon > \epsilon_{\ast}$$where *E*~0~ and *E*~1~ are the moduli of the toe and linear region respectively, *ε*~⁎~ is the strain at which the two linear elements intersect and *c* is a constant to be determined. Similar bi-linear constitutive models have previously been used for biological tissues ([@bib10], [@bib23], [@bib5]).

Hence, in addition to elastic moduli representing the toe region and linear region, the transition point (*ε*~⁎~, *σ*~⁎~) between the toe region and the linear region was also determined, where *ε*~⁎~ is the transition strain and *σ*~⁎~ is the transition stress ([Fig. 2](#f0010){ref-type="fig"}a). The stress and strain of the ligament at failure were not determined as mid-substance failure occurred in only half the specimens tested. However, the load and extension at failure were recorded, in addition to the mechanisms of failure, as indicators of structural performance.Fig. 2(a) Stress--strain data was fitted to a bi-linear model using a custom written Matlab programme, (b) SED was calculated with increasing strain up to 0.15. This was achieved by fitting the stress--strain data to a 3rd order Gaussian function and integrating the resulting function at increments of 0.01 strain.Fig. 2.

The strain energy density (SED) as a function of strain was also determined. This allowed for quantification of the ability of native and decellularised materials to absorb energy within the toe region through to the linear region, but critically it represents the cumulative growth in the area under the stress--strain profiles with incremental strain, and so is a useful indicator to gauge differences in the mechanical performance between the groups.

For each specimen, the following 3rd order Gaussian function was fitted (*r*^2^\>0.99) to the stress--strain data up to the failure point using non-linear least squares regression:$$\sigma\left( \epsilon \right) = \sum\limits_{i{= 1}}^{3}{a_{i}.\exp^{( - {(\frac{\epsilon - b_{i}}{c_{i}})}^{2})}}$$where *a*~*i*~, *b*~*i*~, and *c*~*i*~ are constants to be determined. This has successfully been used in the fitting of stress--strain data for porcine super flexor tendon ([@bib15]).

This was then integrated and evaluated between the limits of 0 and incremental strains of 0.01 until 0.15 strain was reached. 0.15 was chosen as the terminal limit as it represented a strain value approximately half-way into the linear region. This procedure is illustrated in [Fig. 2](#f0010){ref-type="fig"}b. Hence, the SED for native and decellularised groups was assessed throughout the toe region and deep into the linear region, accounting for any strains likely to be encountered during physiological loading.

2.4. Statistical analyses {#s0030}
-------------------------

Student׳s *t*-tests were employed to investigate significance between anthropometrical and biomechanical parameters in native and decellularised groups. Student׳s *t*-tests were also used to determine whether significance existed between both groups for SED at each level of strain investigated. In all cases, a *p*-value of \<0.05 was considered to be statistically significant.

3. Results {#s0035}
==========

The results determined for the gross measurements, moduli, transition point coordinates in addition to the load and extension at failure are presented in [Table 1](#t0005){ref-type="table"}. No significant differences (*p*\>0.05; Student׳s *t*-tests) were found between native and decellularised PT groups for any of the parameters investigated.Table 1Results of the toe region modulus (*E*~*o*~), linear region modulus (*E*~*1*~), transition coordinates (*ε*~⁎~ -- transition strain, *σ*~⁎~ -- transition stress), extension at failure (*δ*~*FAIL*~), load at failure (*P*~*FAIL*~) and failure mechanisms for all specimens tested. Specimens are identified by the donor number, gender and leg from which the specimen is harvested from (i.e. D1-F-R indicates donor 1, female, right leg). No significant differences were found between native and decellularised (D-C) PT groups for any of the parameters investigated (Student׳s *t*-tests; *p*\<0.05).Table 1.*GroupSpecimenE*~*0*~ (MPa)*E*~*1*~ (MPa)*ε*~⁎~ (mm/mm)*σ*~⁎~ (MPa)*δ*~*FAIL*~ (mm)*P*~*FAIL*~ (N)*Failure Mechanism*NativeD1-F-R36.93190.093.411.31790Tibial Bone AvulsionD2-M-L47.94150.073.18.61772Tibial Bone RuptureD3-M-R70.25090.064.38.12439Tibial Bone AvulsionD4-M-L50.42450.084.27.7852Tibial Bone RuptureD5-M-R43.34070.104.210.61762Midsubstance FailureD6-M-R63.94700.074.66.61559Tibial Bone RuptureD7-F-L70.93510.032.411.23141Patellar Bone AvulsionD8-M-L48.73600.094.39.31796Midsubstance FailureMean54.03840.073.89.21889SD12.7840.020.81.766695% CI10.6700.020.61.5557D1-F-L34.32750.134.513.02054Midsubstance FailureD2-M-R67.03180.053.08.11610Tibial Bone AvulsionD-CD3-M-L51.33800.052.78.32113Tibial Bone AvulsionD4-M-R37.35110.082.89.22557Midsubstance FailureD5-M-L35.75310.144.913.01584Tibial Bone AvulsionD6-M-L49.84180.084.08.72386Midsubstance FailureD7-F-R81.84770.086.19.92680Midsubstance FailureD8-M-R70.72950.042.66.21317Midsubstance FailureMean53.54010.083.89.52038SD17.91000.041.32.449595% CI15.0830.031.12.0414

The plots of the mean strain energy density (SED) for both groups against strain are presented in [Fig. 3](#f0015){ref-type="fig"}. Very similar SED profiles were observed for both groups with no significant differences found at any of the strain locations investigated (*p*\>0.05; Student׳s *t*-tests). Hence, the shape and magnitude of the stress--strain profiles were the same for native and decellularised PT groups throughout loading.Fig. 3The SED calculation results as a function of strain for both native and decellularised (D-C) PT groups. Results presented as mean (*n*=8) with 95% confidence intervals. No significant difference was found between groups at any of the levels of strain investigated (Student׳s *t*-tests; *p*\<0.05).Fig. 3.

The failure mechanisms of the specimens are also highlighted in [Table 1](#t0005){ref-type="table"}. In the native PT group there were three specimens that failed due to rupture of the tibial bone within the PMMA cement, three specimens failed due to avulsion at the tendon/bone interface and two mid-substance failures occurred. In the decellularised PT group five mid-substance failures and three tendon/bone interface avulsions occurred.

4. Discussion {#s0040}
=============

Acellular human PT grafts have the potential to be used as a superior alternative to current autologous and allogeneic solutions in ACL replacement. They offer the availability of a product that can be refrigerated until required without tissue necrosis and biomechanical degradation, whilst eliminating the potential problems with harvesting autografts or the immunological issues of allografts. However, it is necessary to establish if the many bio-processes involved in successful decellularisation altered the mechanical properties of the tissue in an adverse manner, as some changes have been observed in similar tissues ([@bib18], [@bib15]). Hence, this study investigated whether the decellularisation bioprocess employed by our group ([@bib36]) altered the material properties of human PT grafts in any appreciable way. This was performed via tensile testing at a low strain rate (0.01 s^−1^) in order to negate the effects of interstitial fluid flow and focus the emphasis on the performance of the solid matrix of the material before and after decellularisation.

By employing a bi-linear model, the elastic modulus of the toe region and linear region, in addition to the transition point co-ordinates were determined for native and decellularised PT specimens. No significant differences were found between groups for any of these parameters. These same parameters were investigated in studies of patellar tendon tissues performed by [@bib4], [@bib5] who also employed a bi-linear model and found very similar values for many parameters, but lower transition strain values. The disparity between the transition points was likely due to a much slower rate of loading being used in this study. The response of human tendons at low strain has been shown to change under extension with larger strain rates, producing higher stresses for the same applied strain ([@bib17]). Consequently, a higher strain rate may result in a shorter toe region and a relocation of the transition point. In fact, toe region mechanics appear more susceptible to varying strain rates than the linear region, as the linear region modulus determined in this study compared well to other studies of the patellar tendon ([@bib3], [@bib12], [@bib5], [@bib4]), even though these studies used higher strain rates. There are also other reports of linear region properties not changing with varying strain rates in human patellar tendon ([@bib3]), in addition to ovine flexor tendon ([@bib23]). Perhaps the key issue may be hydration, as patellar tendon has been found to be significantly more sensitive to strain rate when fully hydrated ([@bib14]).

No significant differences were also observed between the SED profiles for both PT groups, indicating that both the energy absorption and performance of native and decellularised groups were well matched. Importantly, the range over which the SED was measured also covered the physiological range of loading these grafts would encounter if deployed in vivo ([@bib1]).

As not all specimens failed mid-substance, thus the ultimate tensile stress and strain could not be calculated. The structural performance of the specimens was examined instead by determining the load and extension at failure, with no significant differences found between native and decellularised PT groups. However, although mid-substance failure and tendon/bone avulsion were failure mechanisms present in both groups, bone rupture occurred in the native group alone ([Table 1](#t0005){ref-type="table"}). This feature can be explained by the decellularisation process. All the marrow was removed from the bone sections of specimens in the decellularised group, which facilitated the inter-digitation of the PMMA cement with the trabecular bone, enhancing its strength and fixation. Hence, it was less likely that bone rupture would occur in the decellularised PT group during testing. Although the failure mechanisms varied, the data prior to failure was unaffected by this and the measurements of the bi-linear moduli, SED and transition points remain valid.

In a previous study, we found that decellularisation affected the elasticity of juvenile pSFT in the toe region of loading, with more extension required in acellular specimens to reach the equivalent stresses in native controls ([@bib15]). It was suggested that an alteration in the crimping patterns of the collagen fibres could explain this phenomenon. Un-crimping is a commonly used mechanism to describe the non-linear toe region behaviour of tendons and ligaments ([@bib38]; [@bib25], [@bib26]) and differences in crimp angles and periodicity have also been shown to generate different biomechanical load profiles in mitral valve tissue ([@bib21]), the patellar tendon ([@bib37]) and gleno-humeral ligament ([@bib2]). The exact origins of the crimping of fibres are not well understood, but it has been hypothesised that cell contraction plays a role ([@bib16]). Hence, if this is correct, it is intuitive that the removal of cells may alter the crimp pattern, a feature found to occur in decellularised cardiac tissue ([@bib22]). Consequently, this in turn may alter the toe region biomechanics.

However, in this study, no significant difference was found in the toe region mechanics between native human PT and decellularised groups. Possible explanations for this disparity include differences in the tissues involved; particularly that the previously studied animal tissue was juvenile while the human tissue was mature. Although the effects of decellularisation (particularly with reference to the use of SDS) appear to affect some tissues and not others ([@bib41]), perhaps it is the issue of tissue maturity that most warrants further consideration here. There are many microstructural changes associated with patellar tendon development and maturity including collagen crimping and crosslinking ([@bib8], [@bib27]) and it may be that these very changes make the tissue less susceptible to the effects of decellularisation. For example, [@bib27] demonstrated an increase with maturation in both the stiffness and Young׳s modulus of human patellar tendon. The increased stiffness may be due to tendon growth, however Young׳s modulus takes into account the increases in tendon length and cross-section. Hence, the changes in Young׳s modulus may be caused by age-related alterations in the underlying collagen microstructure of the tissue. Crimp angle is known to reduce with age and it has been suggested that this may be a function of changes in the cell to matrix ratio ([@bib20]). Hence, due to a combination of reductions in cell density and collagen crimping angle with maturity, decellularisation could have caused a reduced effect on the matrix structure and likewise the biomechanics.

Changes in HP and LP (hydroxylysyl pyridinoline and lysyl pyridinoline respectively) crosslinks are also known to contribute to the mechanical properties of tendon ([@bib8], [@bib39], [@bib11]) and have been demonstrated to increase in response to reducing collagen density with age to maintain these properties ([@bib8]). Higher proportions of HP and LP crosslinks in mature tissue may also make the tissue more resistant to possible disruptions in the collagen matrix caused by bio-processes involved in decellularisation. Furthermore, these crosslinks are spontaneously formed from immature, chemically reducible, covalent crosslinks in the early stages of development ([@bib28], [@bib8]). In the equine flexor tendon, there is a significant presence of the reducible crosslinks at ages of up to one year, which become HP/LP cross-links with further maturity ([@bib28]). The pSFT (obtained from animals aged 3--6 months) was also likely to have contained significant proportions of reducible cross links, possibly making it more susceptible to bio-processing effects than the mature human PT tissue investigated in this study.

There are limitations in this study worth mentioning. Firstly, strain measurement was determined using the crosshead displacement of the Instron. This assumed that the displacement experienced by the region defined by the gauge length was uniform and the same as the crosshead travel. An attempt was made to use a digital video extensometer to measure the strain, however there was difficulty in tracking the reference markers on the wet tissue. A second limitation was that although the entire PT grafts were decellularised, including the bone extremities, only the mechanical properties of the tendon element were determined. The need to cement the bone for adequate fixation precluded the possibility that this bone could be removed and separately mechanically assessed. Removal of the tendon from the bone so they can be assessed independently is also fraught with difficulties in terms of gripping the tendon specimens and fraying and separation of the collagen fibres once detached from the bone. However, future studies are planned which intend to determine the biomechanical properties of the decellularised bone components. In addition, utilising a porcine patellar tendon model, it is intended to examine the influence of maturity on collagen crimp angles and periodicity, in addition cross-linked collagen content before and after decellularisation. These graft tissues also require assessment under cyclic, physiological loading conditions to determine if significant viscoelastic changes are evident following decellularisation. Previously, our group has demonstrated that glycosaminoglycan (GAG) content is not reduced by decellularisation in porcine PT ([@bib18]). However, we intend to explore the biomechanical effect of any possible GAG reduction in acellular human PT grafts in a further study, scaling up to in-vitro implantation models to determine the dynamic moduli and the contributions of the elastic and viscous components to the grafts.

At the outset, this study aimed to test the hypothesis that the same biomechanical changes found to occur in the pSFT after decellularisation ([@bib15]) would also be present in human PT. However, this hypothesis was refuted as the toe region biomechanics of the human PT graft remained unaffected by decellularisation when tested under quasistatic loading conditions. More fundamentally, this study offers insights that mature tissue may be less susceptible to biomechanical changes caused by decellularisation bioprocesses, possibly due to age-related alterations in the collagen matrix such as crimping and crosslinking.
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